Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HIV组合检测工具获得临床实验室改进修正案豁免

By LabMedica International staff writers
Posted on 14 Apr 2015
一种能检测出人类免疫缺陷病毒(HIV-1/2)抗体和无HIV-1 p24抗原的快速即时检测工具已获得临床实验室改进修正案(CLIA)豁免。
该检测工具已获准在美国销售,供授权开展复杂度中等检验的卫生机构和实验室使用,现在获得此项批准后将可在医生办公室、临床和其他公共卫生环境中使用。
美国食品药品管理局(FDA;Silver Springs,MD,USA)已授权第四代Alere Determine HIV-1/2 Ag/Ab组合检测(Alere;San Diego,CA,USA)豁免CLIA。该检测工具可检测出仅在感染HIV抗体后能出现的p24抗原,此抗原出现在能检测出HIV抗体之前,可能在疾病早期过程检测出HIV感染。早期检测允许医疗服务提供者通过早期诊断和治疗HIV检测阳性的患者改善临床结果。
Rutgers University(Piscataway Township,NJ,USA)的病理学和实验室医学教授,Eugene Martin博士说明,“我很高兴得知Alere Determine HIV-1/2 Ag/Ab组合获得CLIA豁免,并将更广泛的用于HIV筛查。我们都期待第四代快速HIV检验工具,因为这样将允许筛选机构潜在识别早期HIV感染,并尽快引导最可能令其他人面临感染HIV风险的人及早接受治疗。”
Alere感染病全球总监Avi Pelossof说明,“Alere Determine HIV-1/2 Ag/Ab组合的CLIA豁免将有助于促进准确和早期检测HIV,在对于遏制美国艾滋病的蔓延很关键,并通过更接近患者的重要医疗保健服务产生积极的经济影响。扩展检验工具在实验室、医生办公室、临床和其他公共卫生环境的可用性,通过快速诊断推进Alere致力于提供可靠和可操作的信息的承诺。”

Related Links:
US食品药品管理局 
Alere 
Rutgers University 


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.